What is the appropriate management of acute stroke in a child with sickle cell disease?

Management of Acute Stroke in a Child with Sickle Cell Disease

Immediately initiate optimal hydration, correct hypoxemia and hypotension, and perform exchange transfusion to reduce sickle hemoglobin to <30% of total hemoglobin, followed by chronic transfusion therapy for secondary stroke prevention. 1

Acute Management (First 24 Hours)

Immediate Interventions (Class I Recommendations)

The acute management algorithm prioritizes three critical physiologic corrections 1:

• Optimal hydration: Aggressive IV fluid resuscitation to reverse dehydration and reduce blood viscosity
• Correction of hypoxemia: Supplemental oxygen to maintain normal oxygen saturation
• Correction of systemic hypotension: Maintain adequate blood pressure to ensure cerebral perfusion

Transfusion Strategy (Class IIa Recommendation)

Exchange transfusion is the preferred acute intervention 1:

• Target: Reduce sickle hemoglobin (HbS) to <30% of total hemoglobin
• Method: Exchange transfusion is preferred over simple transfusion to avoid increasing blood viscosity from rapid hematocrit elevation
• Timing: Should be performed promptly after initial assessment
• If hemoglobin is >4 gm/dL and <10 gm/dL, proceed with simple transfusion followed immediately by exchange transfusion, or exchange transfusion alone 2

Multidisciplinary Evaluation

Immediate consultation with 2:

• Hematologist
• Neurologist
• Neuroradiologist
• Transfusion medicine specialist

Neuroimaging

Prompt brain imaging (MRI preferred, CT if MRI unavailable) to:

• Confirm ischemic stroke
• Rule out hemorrhagic stroke (which occurs in ~3% of children with SCD) 3
• Identify large vessel vasculopathy or moyamoya syndrome

Important caveat: If intracranial hemorrhage (ICH) is identified, evaluate for structural vascular lesions including aneurysms, as these are relatively common in SCD-associated SAH 1. Defer cerebral angiography until after HbS reduction via transfusion to minimize sickling risk during the procedure 1.

Secondary Stroke Prevention (Long-term Management)

Chronic Transfusion Therapy (Class I Recommendation)

All children with SCD and confirmed cerebral infarction must be placed on a regular program of red cell transfusion 1:

• Frequency: Typically every 3-4 weeks (approximately 14 times per year) 1
• Target: Maintain HbS <30% of total hemoglobin
• Duration: Continue for at least 5 years or until the child reaches 18 years of age 1
• Efficacy: Reduces stroke recurrence from ~20% per year to ~2% per year 1
• Iron overload management: Mandatory chelation therapy to prevent iron accumulation 1

The evidence supporting this approach comes from observational data showing stroke-free survival of 80% at 50 months with chronic transfusion versus 30% without transfusion 1.

Alternative Therapies When Transfusion Not Feasible

Hydroxyurea (Class IIb Recommendation) 1:

• May be considered in children who cannot continue long-term transfusion
• Evidence is weaker than for transfusion therapy
• The TWiTCH trial demonstrated that after at least one year of transfusion, hydroxyurea may be substituted in selected cases 3
• However, the SWiTCH trial showed transfusion remains superior to hydroxyurea for secondary stroke prevention 3

Bone marrow/hematopoietic stem cell transplantation (Class IIb Recommendation) 1:

• May be considered for children with SCD and stroke
• Reportedly stabilizes cerebrovascular disease
• Limited by donor availability and other feasibility issues
• Data remain limited 1

Surgical revascularization (Class IIb Recommendation) 1:

• Consider only as a last-resort option for children who continue to have brain infarctions despite optimal medical management
• Limited evidence: In the largest series of 6 children with SCD and moyamoya who underwent encephaloduro-arteriosynangiosis, outcomes were mixed with one patient developing infarction 2 weeks post-surgery 1
• Natural history poorly understood; requires randomized trial evaluation

Critical Pitfalls to Avoid

1. Do not delay transfusion: Exchange transfusion should occur promptly, not after prolonged diagnostic workup
2. Avoid simple transfusion alone acutely: This can increase blood viscosity; exchange transfusion is preferred 1
3. Do not assume only SCD vasculopathy: Consider other stroke etiologies including infection, cardiac embolism, and cerebral venous sinus thrombosis 1
4. Do not perform cerebral angiography before HbS reduction: If ICH is present and aneurysm suspected, reduce HbS with transfusion first to minimize sickling risk during angiography 1
5. Do not discontinue chronic transfusion prematurely: The STOP II trial showed that discontinuing transfusion leads to high stroke recurrence rates 3

Cognitive and Physical Rehabilitation

A critical but often overlooked component is cognitive and physical rehabilitation following stroke 2. Children with SCD and stroke require:

• Surveillance for developmental delay and cognitive impairments 4, 5
• Formal neurocognitive evaluation
• Physical and occupational therapy as needed

Special Considerations for Resource-Limited Settings

In low-middle-income countries where chronic transfusion may not be feasible 4:

• Hydroxyurea becomes the primary option for secondary prevention
• The SPRING trial in LMICs showed concerning mortality (38% of deaths occurred in first year) highlighting the challenges 6
• Where local hydroxyurea costs <$0.20 per day, it represents a practical option despite being less effective than transfusion 6